Array
(
[id] => 6627666
[patent_doc_number] => 20030211040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'Phosphodiesterase activity and regulation of phosphodiesterase 1B-mediated signaling in brain'
[patent_app_type] => new
[patent_app_number] => 10/233449
[patent_app_country] => US
[patent_app_date] => 2002-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 33730
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20030211040.pdf
[firstpage_image] =>[orig_patent_app_number] => 10233449
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/233449 | Phosphodiesterase activity and regulation of phosphodiesterase 1B-mediated signaling in brain | Sep 2, 2002 | Abandoned |
Array
(
[id] => 5813026
[patent_doc_number] => 20060083713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Methods of using a human il-17 related polypeptide to treat disease'
[patent_app_type] => utility
[patent_app_number] => 10/381094
[patent_app_country] => US
[patent_app_date] => 2001-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28000
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20060083713.pdf
[firstpage_image] =>[orig_patent_app_number] => 10381094
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/381094 | Methods of using a human il-17 related polypeptide to treat disease | Sep 27, 2001 | Abandoned |
Array
(
[id] => 7034172
[patent_doc_number] => 20050032682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Preventives and remedies for diseases in association with demyelination'
[patent_app_type] => utility
[patent_app_number] => 10/312721
[patent_app_country] => US
[patent_app_date] => 2001-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5742
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20050032682.pdf
[firstpage_image] =>[orig_patent_app_number] => 10312721
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/312721 | Pharmaceutical for prevention and treatment of demyelinating disease | Jun 28, 2001 | Issued |
Array
(
[id] => 575710
[patent_doc_number] => 07459524
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-12-02
[patent_title] => 'Chlamydia protein, sequence and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 08/942596
[patent_app_country] => US
[patent_app_date] => 1997-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 20279
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/459/07459524.pdf
[firstpage_image] =>[orig_patent_app_number] => 08942596
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/942596 | Chlamydia protein, sequence and uses thereof | Oct 1, 1997 | Issued |